Gerresheimer Enhances Financial Flexibility for Growth Strategy

Gerresheimer AG, a key player in the pharma, biotech, and cosmetics industries, has bolstered its financial flexibility to support its growth strategy. The company has secured loans totaling EUR 200 million from BayernLB and Landesbank Hessen-Thüringen. These funds will be used to repay part of the bridge financing for the Bormioli Pharma acquisition ahead of schedule.

In addition, Gerresheimer has improved the flexibility of its revolving credit facility of EUR 675 million and the remaining bridge financing of around EUR 525 million. This optimization provides the company with a more predictable and flexible financial structure, allowing it to pursue strategic investments.

CEO Dietmar Siemssen emphasized the company’s commitment to maintaining a solid financial base allowing for targeted growth investments while keeping a focus on free cash flow, aiming for positive results by 2026.